A $100 Million Trial Launched Today to Test Whether GLP-1 Drugs Plus Lifestyle Changes Can Prevent Dementia

Alzheimer’s Association launched the $100M PROTECT-Cog Study July 13, 2026 in London to test GLP-1 drugs plus lifestyle changes as dementia prevention. First global trial of its kind.